WST - CIK 0000105770
WEST PHARMACEUTICAL SERVICES INC trades as WST and has a market capitalization of $23.38 B, making it the #553 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $3.07B, up 6.3% from the prior year and net income of $493.70M. This page tracks WEST PHARMACEUTICAL SERVICES INC through 3,429 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years WEST PHARMACEUTICAL SERVICES INC's revenue grew from $1.51B to $3.07B, a compound annual growth rate of 8.2%. Net profit margin expanded from 12.0% to 16.1% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Major company event (amended) | 8-K/A | 2026-05-20 |
| Insider trade | 4 | 2026-05-14 |
| SD | - | 2026-05-13 |
| Major company event | 8-K | 2026-05-11 |
| Insider sale notice | 144 | 2026-05-07 |
| Insider trade | 4 | 2026-05-06 |
| Insider trade | 4 | 2026-05-06 |
| Insider trade | 4 | 2026-05-06 |
Daikyo Crystal Zenith® Polymer Ready-to-Use Syringe Systems
Daikyo Crystal Zenith® Polymer Ready-to-Use Syringe Systems
Daikyo Crystal Zenith® Polymer Ready-to-Use Syringe Systems
Daikyo Crystal Zenith® Polymer Ready-to-Use Syringe Systems
Daikyo Crystal Zenith® Polymer Ready-to-Use Syringe Systems
The largest companies sharing WEST PHARMACEUTICAL SERVICES INC's SEC industry classification (surgical & medical instruments & apparatus).
WEST PHARMACEUTICAL SERVICES INC (WST) has a market capitalization of $23.38 B as of 2026-06-10, ranking #553 among US-listed companies.
WEST PHARMACEUTICAL SERVICES INC reported revenue of $3.07B for fiscal year 2025, an increase of 6.3% year over year.
Yes. WEST PHARMACEUTICAL SERVICES INC reported net income of $493.70M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.